AEON Biopharma Financials - Benzinga

AEON Biopharma Inc

AEONAMEX

Trade with Public

Trade with Public

$0.2408

-0.0139-5.46%

At close: Sep 4, 5:00 PM EST

$0.2408

N/A

After Hours: 4:16 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

AEON Biopharma Financials

AEON Biopharma (AEON) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of $(0.60) per share from the

Benzinga Newsdesk

PRO
AEON Biopharma Q1 EPS $(0.29) Misses $(0.13) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.13) by 141.67 percent. This is a 112.72 percent decrease over earnings of $2.28 per share from

Benzinga Newsdesk

PRO
AEON Biopharma Q4 EPS $(3.72)

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(3.72) per share. This is a 199.2 percent decrease over earnings of $3.75 per share from the same period last year.

Benzinga Newsdesk

PRO
AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 96.61 percent increase over losses of $(11.52) per share from the

Benzinga Newsdesk

PRO
AEON Biopharma Q2 EPS $(0.60) Beats $(11.52) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(11.52) by 94.79 percent. This is a 100.2 percent decrease over earnings of $304.00 per share from

Benzinga Newsdesk

PRO
AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY

Benzinga Newsdesk